Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

VRTXVRTX
28 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in VERTEX PHARMACEUTICALS INC

Yes. Janus Henderson holds 2,131,527 shares of VRTX (Vertex Pharmaceuticals), worth $951.8M, as of its Q1 2026 13F filing. It reduced the position by 90,426 shares (-4.1%) from Q4 2025. Janus Henderson has held VRTX in every 13F on record since Q2 2019, 28 quarterly filings. VRTX is 0.5% of Janus Henderson's reported 13F portfolio.

Current Value

$951.8M

Current Shares

2.1M

Total Value Change

+$759.3M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
2.1M
-4.1%
$951.8M0.5%$446.54
0
2025-Q4
Increased
2.2M
+4.8%
$1B0.5%$453.36
40
2025-Q3
Decreased
2.1M
-19.1%
$829.9M0.4%$391.64
0
2025-Q2
Decreased
2.6M
-4.7%
$1.2B0.6%$445.20
0
2025-Q1
Decreased
2.7M
-3.0%
$1.4B0.7%$484.82
0
2024-Q4
Increased
2.8M
+12.6%
$1.1B0.6%$402.70
51
2024-Q3
Increased
2.5M
+4.1%
$1.2B0.6%$465.08
47
2024-Q2
Decreased
2.4M
-6.5%
$1.1B0.6%$468.72
0
2024-Q1
Increased
2.6M
+10.4%
$1.1B0.6%$418.01
50
2023-Q4
Increased
2.3M
+41.1%
$952.1M0.6%$406.89
60
2023-Q3
Increased
1.7M
+15.6%
$576.8M0.4%$347.74
43
2023-Q2
Increased
1.4M
+5.0%
$505M0.3%$351.91
39
2023-Q1
Decreased
1.4M
-1.4%
$430.6M0.3%$315.07
0
2022-Q4
Decreased
1.4M
-7.7%
$400.1M0.3%$288.78
0
2022-Q3
Decreased
1.5M
-8.4%
$434.8M0.3%$289.54
0
2022-Q2
Decreased
1.6M
-9.2%
$461.9M0.3%$281.79
0
2022-Q1
Decreased
1.8M
-9.3%
$471.2M0.2%$260.97
0
2021-Q4
Decreased
2M
-6.8%
$437.2M0.2%$219.60
0
2021-Q3
Decreased
2.1M
-50.2%
$387.2M0.2%$181.39
0
2021-Q2
Decreased
4.3M
-4.9%
$864.7M0.4%$201.63
0
2021-Q1
Increased
4.5M
+8.2%
$968.9M0.4%$214.89
41
2020-Q4
Increased
4.2M
+119.2%
$984.7M0.5%$236.34
62
2020-Q3
Decreased
1.9M
-3.2%
$517.3M0.3%$272.12
0
2020-Q2
Increased
2M
+4.9%
$570M0.3%$290.31
39
2020-Q1
Decreased
1.9M
-12.3%
$445.4M0.3%$237.95
0
2019-Q4
Increased
2.1M
+14.0%
$467.4M0.2%$218.95
43
2019-Q3
Increased
1.9M
+78.3%
$317.2M0.2%$169.42
56
2019-Q2
First report
1M
-
$192.5M0.1%$183.38
0

Other major holders of VRTX: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used